Compared to the peak pandemic years of 2020 and 2021, Canada experienced an uptick in prescription drug shortages in 2022 that Health Canada says has continued throughout 2023.
Canada is not alone in experiencing prescription drug shortages, and Health Canada has identified three main factors contributing to the issue: global supply chain disruptions, manufacturing issues, and increased demand.
Efforts are being made to address the issue and improve the situation. Health Canada is collaborating with industry stakeholders to implement strategies like improving communication, expediting approvals for alternative products, and exploring options to boost domestic drug production.
[
add
]
[
|
|
...
]